Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Position statement: global neuraminidase inhibitor susceptibility network.

× No keyword cloud information.

50 in total

1. The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Authors: Wai Lan Wu; Siu-Ying Lau; Yixin Chen; Genyan Wang; Bobo Wing-Yee Mok; Xi Wen; Pui Wang; Wenjun Song; Tianwei Lin; Kwok-Hung Chan; Kwok-Yung Yuen; Honglin Chen
Journal: Antiviral Res Date: 2011-11-25 Impact factor: 5.970

2. Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.

Authors: Hui-Ling Yen; Erich Hoffmann; Garry Taylor; Christoph Scholtissek; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal: J Virol Date: 2006-09 Impact factor: 5.103

3. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

Authors: Gallen B Triana-Baltzer; Rebecca L Sanders; Maria Hedlund; Kellie A Jensen; Laura M Aschenbrenner; Jeffrey L Larson; Fang Fang
Journal: J Antimicrob Chemother Date: 2010-11-21 Impact factor: 5.790

Review 4. Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors: Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal: Antiviral Res Date: 2013-09-04 Impact factor: 5.970

5. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.

Authors: Silvana Carr; Natalia A Ilyushina; John Franks; Elisabeth E Adderson; Miguela Caniza; Elena A Govorkova; Robert G Webster
Journal: Pediatr Infect Dis J Date: 2011-04 Impact factor: 2.129

6. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.

Authors: Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Maryna C Eichelberger; Jeffery K Taubenberger
Journal: Clin Infect Dis Date: 2010-05-01 Impact factor: 9.079

7. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.

Authors: Maki Kiso; Kazumi Takahashi; Yuko Sakai-Tagawa; Kyoko Shinya; Saori Sakabe; Quynh Mai Le; Makoto Ozawa; Yousuke Furuta; Yoshihiro Kawaoka
Journal: Proc Natl Acad Sci U S A Date: 2009-12-22 Impact factor: 11.205

8. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

Authors: N T Wetherall; T Trivedi; J Zeller; C Hodges-Savola; J L McKimm-Breschkin; M Zambon; F G Hayden
Journal: J Clin Microbiol Date: 2003-02 Impact factor: 5.948

9. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Authors: Siri H Hauge; Susanne Dudman; Katrine Borgen; Angie Lackenby; Olav Hungnes
Journal: Emerg Infect Dis Date: 2009-02 Impact factor: 6.883

10. Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.

Authors: Gallen B Triana-Baltzer; Larisa V Gubareva; Alexander I Klimov; David F Wurtman; Ronald B Moss; Maria Hedlund; Jeffrey L Larson; Robert B Belshe; Fang Fang
Journal: PLoS One Date: 2009-11-06 Impact factor: 3.240